[Clinical evaluation of Peridontone ointment for topical treatment of oral mucosa erosions and small ulcerations].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005601:Framycetin / Q000627:therapeutic use; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010206:Papain / Q000627:therapeutic use; D012964:Sodium; D013280:Stomatitis / Q000188:drug therapy*; D013281:Stomatitis, Aphthous / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D001565:Benzoates; D004338:Drug Combinations; D005601:Framycetin; D012964:Sodium; D010206:Papain
Ocena kliniczna maści péridontone w leczeniu miejscowym spraw nadzerkowych i ograniczonych owrzodzeń jamy ustnej.